Tumor osteomimicry is defined as the ability of cancer cells to express a bone-specific protein profile, including osteocalcin, OPN, and receptor activator of nuclear factor kappa-Β ligand (RANKL), which induce seeding of cancer cells in bone microenvironment (Macedo et al., 2017). This evidence concerns the gene TNFSF11 and cancer.